V2 Financial group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
V2 Financial group's PFE Position: Q2 2026 in Review
V2 Financial group increased its Pfizer (PFE) stake by 1.6% in Q2 2026, buying an estimated $11.8K and bringing the position to 29,665 shares worth $714K. The position accounts for 0.27% of the portfolio, ranked #48.
V2 Financial group first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.31M in Q4 2021. 2,832 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- V2 Financial group held 29,665 shares of Pfizer worth $714K as of Q2 2026.
- V2 Financial group bought 453 Pfizer shares in Q2 2026, an estimated $11.8K.
- Pfizer made up 0.27% of V2 Financial group's portfolio in Q2 2026, its #48 holding.
- V2 Financial group first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
- V2 Financial group's Pfizer position peaked at $3.31M in Q4 2021.
- 2,832 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on V2 Financial group's 13F filing for Q2 2026, filed 11 Aug 2026.